Dermapharm AG agreed to acquire Trommsdorff GmbH & Co. KG from Grupo Ferrer Internacional, S.A., and others in December 2017. Dermapharm plans to partially finance the acquisition of Trommsdorff through an initial public offering of €100 million. Trommsdorff reported turnover of €51 million in 2017. The acquisition of Trommsdorff is subject to approval by the German Federal Cartel Office and is expected to close in the first quarter of 2018. Matthias Bruse, Nico Fischer, Daniel Wiedmann, Matthias Werner, Susanne Bitzinger, Philipp Kopp and Thies Jacob of P+P Pöllath + Partners acted as legal advisor to Dermapharm AG. FERBER & CO. acted as financial advisor to Dermapharm AG. Deloitte acted as accountant to Grupo Ferrer Internacional, S.A.